Visible and NIR Upconverting Er3+–Yb3+ Luminescent Nanorattles and Other Hybrid PMO‐Inorganic Structures for In Vivo Nanothermometry
Source abstract
Abstract
Abstract Lanthanide‐doped luminescent nanoparticles are an appealing system for nanothermometry with biomedical applications due to their sensitivity, reliability, and minimal invasive thermal sensing properties. Here, four unique hybrid organic–inorganic materials prepared by combining β‐NaGdF4 and PMOs (periodic mesoporous organosilica) or mSiO2 (mesoporous silica) are proposed. PMO/mSiO2 materials are excellent candidates for biological/biomedical applications as they show high biocompatibility with the human body. On the other hand, the β‐NaGdF4 matrix is an excellent host for doping lanthanide ions, even at very low concentrations with yet very efficient luminescence properties. A new type of Er3+–Yb3+ upconversion luminescence nanothermometers operating both in the visible and near infrared regime is proposed. Both spectral ranges permit promising thermometry performance even in aqueous environment. It is additionally confirmed that these hybrid materials are non‐toxic to cells, which makes them very promising candidates for real biomedical thermometry applications. In several of these materials, the presence of additional voids leaves space for future theranostic or combined thermometry and drug delivery applications in the hybrid nanostructures.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Luminescence Properties of Advanced Materials · Nanoplatforms for cancer theranostics · Inorganic Fluorides and Related Compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry Ghent University Krijgslaan 281‐S3 Ghent 9000 Belgium
Debye Institute for Nanomaterials Science Utrecht University Princetonplein 1 Utrecht 3584 CC The Netherlands
Department of Biotechnology Faculty of Bioscience Engineering Ghent University Ghent 9000 Belgium
Funding
Fonds Wetenschappelijk Onderzoek · Horizon 2020 Framework Programme · Universiteit Gent
References (51)
Show source-provided references
1. Dramicanin M. · 2018
2. 10.1002/adom.20180123910.1002/adom.201801239 ↗
3. 10.1039/c2nr30764b10.1039/c2nr30764b ↗
4. Carlos L. D. · 2016
5. 10.1002/chem.20160086010.1002/chem.201600860 ↗
6. 10.1039/C4CC07038K10.1039/C4CC07038K ↗
7. 10.1002/adfm.20150051810.1002/adfm.201500518 ↗
8. 10.1039/c2nr32203j10.1039/c2nr32203j ↗
9. 10.1039/c2nr30663h10.1039/c2nr30663h ↗
10. 10.1002/adfm.20120171210.1002/adfm.201201712 ↗
11. 10.1021/nn100244a10.1021/nn100244a ↗
12. 10.1021/acs.inorgchem.5b0192410.1021/acs.inorgchem.5b01924 ↗
13. 10.1002/adfm.20150533210.1002/adfm.201505332 ↗
14. 10.1002/adma.20160117610.1002/adma.201601176 ↗
15. 10.1021/nn402608w10.1021/nn402608w ↗
16. 10.1039/C8TC01062E10.1039/C8TC01062E ↗
17. 10.1039/C8NR08348G10.1039/C8NR08348G ↗
18. 10.1039/C7TC00921F10.1039/C7TC00921F ↗
19. 10.3390/nano1003054310.3390/nano10030543 ↗
20. 10.1002/anie.20191398310.1002/anie.201913983 ↗
21. 10.1039/b406082m10.1039/b406082m ↗
22. 10.1021/ar040089410.1021/ar0400894 ↗
23. 10.3762/bjnano.6.23510.3762/bjnano.6.235 ↗
24. 10.3389/fchem.2019.0021810.3389/fchem.2019.00218 ↗
25. 10.1002/adhm.20170083110.1002/adhm.201700831 ↗
26. 10.1039/C5NR05649G10.1039/C5NR05649G ↗
27. 10.1039/C8CS00234G10.1039/C8CS00234G ↗
28. 10.1021/acsami.0c0147010.1021/acsami.0c01470 ↗
29. 10.1039/C8TC06353B10.1039/C8TC06353B ↗
30. 10.1039/c0nr00893a10.1039/c0nr00893a ↗
31. 10.1039/C4TC02553A10.1039/C4TC02553A ↗
32. 10.1039/C8RA01752B10.1039/C8RA01752B ↗
33. 10.1039/C6DT01555G10.1039/C6DT01555G ↗
34. 10.3390/nano904064610.3390/nano9040646 ↗
35. 10.1021/acsnano.8b0154510.1021/acsnano.8b01545 ↗
36. 10.1039/C7DT01058C10.1039/C7DT01058C ↗
37. 10.1039/C7DT02042B10.1039/C7DT02042B ↗
38. 10.1063/1.166989310.1063/1.1669893 ↗
39. 10.3390/nano1004062710.3390/nano10040627 ↗
40. 10.1002/anie.20050459910.1002/anie.200504599 ↗
41. ISO 10993‐5:2009 Biological evaluation of medical devices—Part 5: Tests for in vitro cytotoxicity Canadian Standards Association2007 pp.1–11.
42. 10.1021/acsnano.9b0882410.1021/acsnano.9b08824 ↗
43. 10.1021/acs.jpcc.7b0482710.1021/acs.jpcc.7b04827 ↗
44. 10.1021/nn200110j10.1021/nn200110j ↗
45. 10.1002/adfm.20170736510.1002/adfm.201707365 ↗
46. 10.1039/c3ra47654e10.1039/c3ra47654e ↗
47. 10.1002/chem.20100064310.1002/chem.201000643 ↗
48. 10.1007/s12274-015-0979-410.1007/s12274-015-0979-4 ↗
49. 10.1002/anie.20150146810.1002/anie.201501468 ↗
50. 10.1002/ppsc.20160016610.1002/ppsc.201600166 ↗
51. 10.1016/j.snb.2018.06.08610.1016/j.snb.2018.06.086 ↗